News & Updates

Show Multimedia Only

Maternal stroke tied to high morbidity, mortality

25 Feb 2022 by

Women who experienced a stroke during pregnancy had higher rates of morbidity and mortality compared with those without stroke, according to a study presented at ISC 2022.

Maternal stroke tied to high morbidity, mortality

25 Feb 2022

DOACs as effective as warfarin for CVT with lower bleeding risk

24 Feb 2022 by

The risk of recurrent venous thrombosis in patients with cerebral venous thrombosis (CVT) was comparable between those who received warfarin or direct oral anticoagulants (DOACs), according to results of the ACTION-CVT* study presented at ISC 2022.

DOACs as effective as warfarin for CVT with lower bleeding risk

24 Feb 2022

Blood pressure shows J-shaped relationship with death risk in post-PCI CAD patients

24 Feb 2022

A recent Korea study has found a J-shaped relationship between mortality risk and blood pressure (BP) in coronary artery disease (CAD) patients undergoing percutaneous coronary intervention (PCI).

Blood pressure shows J-shaped relationship with death risk in post-PCI CAD patients

24 Feb 2022

All-inclusive organs: Lungs successfully converted to universal blood type

24 Feb 2022 by

Lungs donated for transplants can now be converted to a universal blood type, making the organs compatible with any patient, as shown in a recent study. This medical feat is expected to dramatically improve organ allocation in transplants worldwide.

All-inclusive organs: Lungs successfully converted to universal blood type

24 Feb 2022

Long-term rituximab safe, effective in primary Sjögren syndrome

24 Feb 2022

Treatment with rituximab (RTX) in the long term is safe and well tolerated in patients with primary Sjögren syndrome (pSS), claims a recent study. In addition, long-term RTX demonstrates effectiveness in significantly reducing European Alliance of Associations for Rheumatology (EULAR) Sjögren’s Syndrome Disease Activity Index (ESSDAI) values and controlling disease activity.

Long-term rituximab safe, effective in primary Sjögren syndrome

24 Feb 2022

Baricitinib keeps radiographic progression levels low in rheumatoid arthritis

24 Feb 2022 by

Treatment with oral baricitinib steadily inhibits radiographic progression of structural joint damage in most patients with rheumatoid arthritis (RA), while achieving clinical improvement in disease activity, through 5 years as compared with initial conventional synthetic disease-modifying antirheumatic drug (csDMARD) or placebo, results of a study have shown.

Baricitinib keeps radiographic progression levels low in rheumatoid arthritis

24 Feb 2022

Evolution Haemophilia Care: Where are we now

24 Feb 2022

Hemofilia merupakan gangguan perdarahan yang bersifat X-linked recessive, yang menyebabkan defisiensi faktor VIII (hemofilia A) atau faktor IX (hemofilia B). Insidens hemofilia lebih banyak terjadi pada anak dibandingkan dengan orang dewasa. Perdarahan spontan yang dapat berdampak serius terhadap kondisi kesehatan, serta penanganan yang tepat sangat diperlukan agar tidak menimbulkan perburukan dan komplikasi yang fatal. Upaya profilaksis untuk mencegah komplikasi dan sekaligus meningkatkan kualitas hidup pasien hemofilia menjadi pokok diskusi para pakar kesehatan dalam acara kongres virtual nasional Ilmu Kesehatan Anak (KONIKA) ke18 pada pertengahan bulan Oktober 2021 di Medan dengan 2 narasumber yaitu DR. Dr. Novie Amelia Chozie, Sp.A(K) dari FKUI/RSCM Jakarta dan dr. Koh Pei Lin dari NUH Singapura, dan dimoderatori oleh Dr. Bambang Sudarmanto, Sp.A(K), MARS.

Evolution Haemophilia Care: Where are we now

24 Feb 2022

Adherence to low-carbohydrate diet inversely tied to rs671 polymorphism

24 Feb 2022

An inverse relationship is observed between rs671 and adherence to low-carbohydrate diets (LCD), reveals a Japan study. This association, however, is strongly confounded by alcohol consumption.

Adherence to low-carbohydrate diet inversely tied to rs671 polymorphism

24 Feb 2022

PPE-related adverse effects compromise HCWs’ work quality

24 Feb 2022 by

Healthcare workers (HCW) commonly report side effects associated with the use of personal protective equipment (PPE), according to a recent Singapore study. In turn, HCWs say that these side effects negatively impact their work.

PPE-related adverse effects compromise HCWs’ work quality

24 Feb 2022

Add-on trilaciclib boosts antitumour effects of chemo combinations for triple-negative breast cancer

24 Feb 2022

Pretreatment with the cyclin-dependent kinase 4/6 inhibitor trilaciclib appears to enhance the antitumour efficacy of gemcitabine plus carboplatin, with significant survival gains for patients with metastatic triple-negative breast cancer (mTNBC), according to the results of a phase II trial.

Add-on trilaciclib boosts antitumour effects of chemo combinations for triple-negative breast cancer

24 Feb 2022

News & Updates

Filter by Specialty:

Specialty:

Maternal stroke tied to high morbidity, mortality

Maternal stroke tied to high morbidity, mortality

DOACs as effective as warfarin for CVT with lower bleeding risk

DOACs as effective as warfarin for CVT with lower bleeding risk

Blood pressure shows J-shaped relationship with death risk in post-PCI CAD patients

Blood pressure shows J-shaped relationship with death risk in post-PCI CAD patients

All-inclusive organs: Lungs successfully converted to universal blood type

All-inclusive organs: Lungs successfully converted to universal blood type

Long-term rituximab safe, effective in primary Sjögren syndrome

Long-term rituximab safe, effective in primary Sjögren syndrome

Baricitinib keeps radiographic progression levels low in rheumatoid arthritis

Baricitinib keeps radiographic progression levels low in rheumatoid arthritis

Evolution Haemophilia Care: Where are we now

Evolution Haemophilia Care: Where are we now

Adherence to low-carbohydrate diet inversely tied to rs671 polymorphism

Adherence to low-carbohydrate diet inversely tied to rs671 polymorphism

PPE-related adverse effects compromise HCWs’ work quality

PPE-related adverse effects compromise HCWs’ work quality

Add-on trilaciclib boosts antitumour effects of chemo combinations for triple-negative breast cancer

Add-on trilaciclib boosts antitumour effects of chemo combinations for triple-negative breast cancer